Bacterial strains capable of metabolizing oxalates

US10982184B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10982184-B2
Application numberUS-201214116996-A
CountryUS
Kind codeB2
Filing dateMay 9, 2012
Priority dateMay 9, 2011
Publication dateApr 20, 2021
Grant dateApr 20, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A selection of strains of lactic bacteria and bifidobacteria of human intestinal origin capable of metabolizing oxalates is described. Moreover, a food composition or supplement product or pharmaceutical composition containing said bacterial strains is also described.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for preventive and/or curative treatment in a subject of hyperoxaluria, urolithiasis, kidney failure, cardiopathies, kidney stones, diverticulosis and diverticulitis, the method comprising administering to the subject a food composition or supplement product or medical device or pharmaceutical composition comprising a bacterial composition, said bacterial composition comprising the strain L. paracasei spp. paracasei LPC 09 DSM 24243. 2. The method according to claim 1 , wherein the composition further comprises at least one bacterial strain selected from the group consisting of the bacterial strain L. gasseri LGS 01 DSM 18299 and the bacterial strain L. gasseri LGS 02 DSM 18300. 3. The method according to claim 1 , wherein the composition further comprises bacterial strain L. acidophilus LA02 DSM 21717 and the bacterial strain L. acidophilus LA 07 DSM 24303. 4. The method according to claim 1 , wherein the composition further comprises fructo-oligosaccharides and inulin. 5. The method according to claim 1 , wherein said bacterial composition consists of L. paracasei spp. paracasei LPC 09 DSM 24243 , L. acidophilus LA02 DSM 21717 and L. acidophilus LA 07 DSM 24303. 6. The method according to claim 2 , wherein the composition further comprises fructo-oligosaccharides and inulin.

Assignees

Inventors

Classifications

  • Lactobacillus · CPC title

  • Bacterial isolates · CPC title

  • Drugs for disorders of the urinary system · CPC title

  • Fructosans, e.g. inulin · CPC title

  • Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10982184B2 cover?
A selection of strains of lactic bacteria and bifidobacteria of human intestinal origin capable of metabolizing oxalates is described. Moreover, a food composition or supplement product or pharmaceutical composition containing said bacterial strains is also described.
Who is the assignee on this patent?
Mogna Giovanni, Strozzi Gian Paolo, Mogna Luca, and 1 more
What technology area does this patent fall under?
Primary CPC classification C12N1/20. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).